Market Update: Milestone Pharmaceuticals Inc (MIST) Sees Negative Movement, Closing at 2.21

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

In the latest session, Milestone Pharmaceuticals Inc (NASDAQ: MIST) closed at $2.21 down -2.64% from its previous closing price of $2.27. In other words, the price has decreased by -$2.64 from its previous closing price. On the day, 0.75 million shares were traded.

Ratios:

For a deeper understanding of Milestone Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.40 and its Current Ratio is at 15.40. In the meantime, Its Debt-to-Equity ratio is 2.25 whereas as Long-Term Debt/Eq ratio is at 2.23.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $9.

On June 20, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $4.

Piper Sandler Upgraded its Neutral to Overweight on April 22, 2022, whereas the target price for the stock was revised from $8 to $10.

Stock Price History:

Over the past 52 weeks, MIST has reached a high of $2.75, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is 9.32%, while the 200-Day Moving Average is calculated to be 33.23%.

Shares Statistics:

A total of 53.33M shares are outstanding, with a floating share count of 50.14M. Insiders hold about 5.97% of the company’s shares, while institutions hold 41.12% stake in the company.

Most Popular